The strengths of this study include the use of a large population-based and nationwide sample: over 15,000 patients with ASCVD were characterised for CRP levels, demographic and clinical characteristics, treatment patterns, and a set of biomarkers routinely monitored in clinical practice. Here, CRP is linked to atherosclerosis.